Tigermed
Stage
IPOTotal Raised
$7MInvestors Count
1Deal Terms
1Portfolio Exits
9Investments
65Funding, Valuation & Revenue
2 Fundings
Tigermed's latest funding round was a IPO for $80M on August 27, 2012.
Tigermed's latest post-money valuation is from August 2012.
Sign up for a free trial to see Tigermed's valuations in August 2012 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
8/27/2012 | IPO | $80M | 1 | |||
7/14/2008 | Series A |
Date | 8/27/2012 | 7/14/2008 |
|---|---|---|
Round | IPO | Series A |
Amount | $80M | |
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Tigermed Deal Terms
1 Deal Term
Tigermed's deal structure is available for 1 funding round, including their IPO from August 27, 2012.
Round | IPO |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO |
Tigermed Investors
1 Investors
Tigermed has 1 investors. Qiming Venture Partners invested in Tigermed's Series A funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/14/2008 | 7/14/2008 | 1 Series A | Venture Capital | China |
First funding | 7/14/2008 |
|---|---|
Last Funding | 7/14/2008 |
Investor | |
Rounds | 1 Series A |
Board Seats | |
Type | Venture Capital |
Location | China |
Tigermed Acquisitions
3 Acquisitions
Tigermed acquired 3 companies. Their latest acquisition was Marti Farm on January 19, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/19/2023 | Acquired | 1 | ||||
12/2/2015 | ||||||
7/30/2014 | Other Venture Capital |
Date | 1/19/2023 | 12/2/2015 | 7/30/2014 |
|---|---|---|---|
Investment Stage | Other Venture Capital | ||
Companies | |||
Valuation | |||
Total Funding | |||
Note | Acquired | ||
Sources | 1 |
Tigermed Investments
65 Investments
Tigermed has made 65 investments. Their latest investment was in ProteLight Pharma as part of their Series D - II on January 1, 2023.
Tigermed Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/17/2023 | Series D - II | ProteLight Pharma | Yes | 1 | ||
12/6/2022 | Series A | Weisijin Bio | $21.44M | Yes | Guanghua Wutong, Mansaisi, Tigermed, Undisclosed Investors, Wintop capital, and YINGKE PE | 2 |
10/14/2022 | Series B | Haibert | No | 1 | ||
7/28/2022 | Seed | |||||
5/25/2022 | Series B - III |
Date | 1/17/2023 | 12/6/2022 | 10/14/2022 | 7/28/2022 | 5/25/2022 |
|---|---|---|---|---|---|
Round | Series D - II | Series A | Series B | Seed | Series B - III |
Company | ProteLight Pharma | Weisijin Bio | Haibert | ||
Amount | $21.44M | ||||
New? | Yes | Yes | No | ||
Co-Investors | Guanghua Wutong, Mansaisi, Tigermed, Undisclosed Investors, Wintop capital, and YINGKE PE | ||||
Sources | 1 | 2 | 1 |
Tigermed Portfolio Exits
9 Portfolio Exits
Tigermed has 9 portfolio exits. Their latest portfolio exit was 3DMED Biomedical on December 15, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
12/15/2022 | IPO | Public | 1 | ||
Date | 12/15/2022 | ||||
|---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.